CEL-SCI Corporation (CVM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated July 11, 2025, reports on a material definitive agreement entered into by CEL-SCI Corporation. The filing details a priced-at-the-market equity offering that closed on July 14, 2025.
Key Financial Metrics
- Offering Size: 1,500,000 shares of common stock.
- Offering Price: $3.82 per share.
- Gross Proceeds: Approximately $5,730,000.
- Placement Agent Fee: 7.0% of gross proceeds.
- Expense Reimbursement: Up to $95,000.
- Use of Proceeds: Funding continued development of Multikine, general corporate purposes, and working capital.
Note: This filing does not provide data on revenue, profit, cash flow, margins, or existing debt levels.
Material Changes and Agreements
The Company entered into a Placement Agency Agreement with ThinkEquity LLC. Key terms include:
- Lock-Up Periods: The Company agreed not to issue or announce new equity for 30 days from July 11, 2025. Directors and officers are subject to a 45-day lock-up on their existing holdings.
- Regulatory Basis: Securities were sold pursuant to an effective Form S-3 registration statement (No. 333-265995).
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds to advance the development of Multikine. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially from projections. Investors are directed to the "Risk Factors" section in the prospectus supplement and the Annual Report on Form 10-K for the fiscal year ended September 30, 2024, for a comprehensive list of risks.
Key Facts for Investor Verification
- Verify the exact net proceeds after deducting the 7.0% fee and up to $95,000 in expenses.
- Confirm the dilution impact of the 1,500,000 new shares on existing shareholders.
- Review the specific milestones for the Multikine development program to assess capital efficiency.
- Check the Company's current cash position and burn rate to determine runway extension provided by this offering.